Wegovy, the weight-loss brand of semaglutide, has a recommended maintenance dose of 2.4 mg. Novo ran the Phase III STEP UP ...

Wegovy can cause side effects ... used for weight loss and weight management in: adults and children ages 12 years and older with obesity adults who are overweight and have at least one weight ...

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...

Fresh questions are being asked about the use of weight loss injections ... with a body mass index (BMI) of more than 35 - considered class 2 and class 3 obesity - and at least one weight-related ...

The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

The development of GLP-1 drugs, such as Wegovy ... muscle loss than expected for the achieved decline in weight. How do we know if muscle loss on GLP-1 drugs is unhealthy? One of the obstacles ...

IT’S NOT ALL about shedding pounds and curbing hunger. GLP-1 drugs used for weight loss involve all kinds of side effects—good and not-so-good—that may or may not strike the average user.

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." IT’S NOT ALL about shedding pounds and curbing hunger. GLP-1 drugs used for weight loss involve all ...